"Early detection of cancer saves lives, so there should be no hesitation in allowing Medicare to cover the latest diagnosis tools once they have been shown effective. Newly emerging multi-cancer early detection testing also has the potential to reduce disparities in cancer treatment and outcomes that persist in communities of color, which experience higher rates of incidence and death due to lower rates of routine cancer screening. I am proud to work with my colleagues to provide a pathway for multi-cancer screening technologies that would help increase cancer screening rates."